Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 binding and neutralizing antibodies of injecting drug users.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas - 1 Sept 2005

Ouverney E P, Teixeira S L M, Silva-de-Jesus C, Hacker M A, Morgado M G, Bastos F I, Bongertz V

Abstract excerpt

Previous studies have demonstrated a stronger seroreactivity against some synthetic peptides responsible for inducing neutralizing antibodies in injecting drug users (IDU) compared to that of individuals sexually infected with HIV-1 (S), but the effectiveness in terms of the neutralizing ability of these antibodies has not been evaluated. Our objective was to study the humoral immune response of IDU by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV-1
Share to Cross Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Antibodies

Share to HIV Antigens

Share to HIV Infections

Share to Neutralization Tests

Share to Substance Abuse, Intravenous

Source

Identifiers

PMID: 16138213
DOI: 10.1590/s0100-879x2005000900004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

HIV-1 binding and neutralizing antibodies of injecting drug users.PMID 16138213Read ↗

Human immunodeficiency virus type 1 neutralization by plasma from B or F genotype infected individuals.Semantic proximity Read ↗

Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatment.Semantic proximity Read ↗

V3 peptide binding pattern and HIV-1 transmission route in Rio de Janeiro.Semantic proximity Read ↗

Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: evidence of subtype homogeneity at the main sites of the epidemic.Semantic proximity Read ↗

CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In VitroSemantic proximity Read ↗

Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.Semantic proximity Read ↗

Infection by Discordant Strains of HIV-1 Markedly Enhances the Neutralizing Antibody Response against Heterologous VirusSemantic proximity Read ↗

Human Immunodeficiency Virus Type 1 Neutralizing Antibody Serotyping Using Serum Pools and an Infectivity Reduction AssaySemantic proximity Read ↗

Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.